Diphenhydramine Hcl Tablet, Film Coated
Product Images NDC 0536-1214

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hcl (NDC 0536-1214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

44-329 (Rugby 44 329 1)

This is a drug information leaflet that contains warnings, directions, and instructions for use for a medication. The medication is advised against if the user is taking sedatives or tranquilizers, as marked drowsiness may occur, and driving or operating machinery should be avoided while using. The medication should not be taken more than directed, adults and children over 12 should take 1-2 tablets every 4 to 6 hours, and should not exceed six doses in 24 hours. Children 6 to under 12 years should take 1 tablet, and children under 6 should not use the medication. The tablets contain calcium, corn starch, and other ingredients. If an overdose is suspected, medical attention should be sought immediately. If pregnant or breastfeeding, the user should consult a healthcare professional before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.